Trial intelligence / Profile preview

Hydrocortisone, Vitamin C, and Thiamine for Sepsis and Septic Shock

NCT03258684Completed

Sponsor
Southern Medical University Zhujiang Hospital
Start
Sep 2017
Primary completion
Feb 2019
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of ascorbic acid, hydrocortisone and thiamine in sepsis and septic shock (2 arms), sponsored by Southern Medical University Zhujiang Hospital. Primary endpoint: Hospital survival at 14 days. Started Sep 2017; status: completed.

02

Drugs

ascorbic acidhydrocortisonethiamine
03

Conditions

sepsisseptic shock

Beyond the preview

Go deeper on NCT03258684.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03258684.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call